首页 >
法规速递
-
Document: Chapter 3.II: XEVPRM detailed user guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the EMA-2026/4/16
2026-04-17查看详情 > -
Page: Enpr-EMA priority activities-2026/5/29
2026-05-31查看详情 > -
Document: Minutes of the COMP meeting 11-12 May 2026-2026/7/13
2026-07-14查看详情 > -
国家药监局关于修订盐酸赖氨酸注射剂说明书的公告（2023年第11号）-2023/01/16
2023-01-16查看详情 > -
关于公开征求《硫唑嘌呤片生物等效性研究指导原则（征求意见稿）》等六项技术指导原则意见的通知-2023/8/22
2023-08-23查看详情 > -
国家药监局药审中心关于发布《罕见病酶替代疗法药物非临床研究指导原则（试行）》的通告（2024年第17号）-2024/2/23
2024-03-12查看详情 > -
Institutional Review Board (IRB) Written Procedures-2025/2/5
2025-02-06查看详情 > -
Document: Superseded opinion of the HMPC on Urtica dioica L., Urtica urens L. their hybrids or their mixtures, radix - First version-2025/3/12
2025-03-13查看详情 > -
Page: Eligible patients and consumers organisations-2025/4/14
2025-04-15查看详情 > -
Document: CTIS newsflash - 27 May 2025-2025/5/27
2025-05-28查看详情 >
